关注
Akshatha Handattu Shankaranarayana
Akshatha Handattu Shankaranarayana
其他姓名Akshatha H S, H S Akshatha, A H. S
Research Scholar, Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Mysore
在 jssuni.edu.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Evolution of Machine Learning in Tuberculosis Diagnosis: A Review of Deep Learning-Based Medical Applications
M Singh, GV Pujar, S Arun Kumar, M Bhagyalalitha, HS Akshatha, ...
Electronics-MDPI 11 (2634), 24, 2022
582022
Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development
B Meduri, GV Pujar, TDA Kumar, HS Akshatha, AK Sethu, M Singh, ...
European Journal of Medicinal Chemistry 222, 113574, 2021
352021
Machine learning and deep learning in data-driven decision making of drug discovery and challenges in high-quality data acquisition in the pharmaceutical industry
SA Kumar, TD Ananda Kumar, NM Beeraka, GV Pujar, M Singh, ...
Future Medicinal Chemistry 14 (4), 245-270, 2022
342022
Dengue Structural Proteins as Antiviral Drug Targets: Current Status in the Drug Discovery & Development
A H. S, GV Pujar, AK Sethu, M Bhagyalalitha, M Singh
European Journal of Medicinal Chemistry, 113527, 2021
162021
Application of liquid chromatography coupled with mass spectrometry in the impurity profiling of drug substances and products
A HS, G BM
Asian J Pharm Clin Res 11 (5), 30-37, 2018
102018
Nano theranostics—A breakthrough in cancer diagnosis and treatment and regulations of nano technology products
SP Medavenkata, HS Akshatha
Int. J. Pharm. Sci. Res 9, 3136-3149, 2018
72018
Validated Method for the Simultaneous Estimation of Orphenadrine Citrate and Paracetamol in Tablets by Simultaneous Equation Method
HS Akshatha, BM Gurupadayya, PP Raikar
Int. J. ChemTech Res 11 (7), 45-55, 2018
62018
Restoration of p53 functions by suppression of mortalin–p53 sequestration: an emerging target in cancer therapy
AH Shankaranarayana, B Meduri, GV Pujar, RC Hariharapura, AK Sethu, ...
Future Medicinal Chemistry 15 (22), 2087-2112, 2023
52023
New LPA1 receptor modulators: Design, synthesis, in-silico, and anticancer studies of triazole and oxadiazole analogs
B Meduri, SR Pavan, A Prabhu, AH Shankaranarayana, AK Sethu, ...
Journal of Molecular Structure 1295, 136672, 2024
42024
Novel Antitubercular Agents: Design, Synthesis, Molecular Dynamic and Biological Studies of Pyrazole–1, 2, 4‐Triazole Conjugates
KA Ajin, S Arun Kumar, M Singh, HS Akshatha, M Bhagyalalitha, KG Pujar, ...
Chemistry & biodiversity 20 (11), e202300971, 2023
32023
Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment
M Bhagyalalitha, AH Shankaranarayana, SA Kumar, M Singh, KG Pujar, ...
Bioorganic Chemistry, 107695, 2024
2024
Design, synthesis and evaluation of new thiazolidin-4-ones as LPA1 receptor antagonists for breast cancer therapy
M Bhagyalalitha, A Prabhu, A Hs, SA Kumar, M Singh, KG Pujar, GV Pujar
Future Medicinal Chemistry 16 (8), 769-790, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–12